- High gross margin of 98.9%
- Lower volatility than the market (beta 0.28)
- Low bankruptcy risk (Altman Z-Score: 15.70)
Green day on Wednesday for Crinetics Pharmaceuticals Inc stock after gaining 1.47%
(Updated on Jun 03, 2026)
The Crinetics Pharmaceuticals Inc stock price gained 1.47% on the last trading day (Wednesday, 3rd Jun 2026), rising from $32.61 to $33.09. During the last trading day the stock fluctuated 3.16% from a day low at $32.56 to a day high of $33.59. The price has fallen in 6 of the last 10 days and is down by -5.29% for this period. Volume fell on the last day by -10 thousand shares and in total, 838 thousand shares were bought and sold for approximately $27.74 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $32.60 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Crinetics Pharmaceuticals Inc stock with a 90% probability to be traded between $32.08 and $42.59 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
CRNX Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 1.47%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Crinetics Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $35.05 and $37.82. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Crinetics Pharmaceuticals Inc stock
Crinetics Pharmaceuticals Inc finds support from accumulated volume at $32.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.03 between high and low, or 3.16%. For the last week, the stock has had daily average volatility of 3.82%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CRNX) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Crinetics Pharmaceuticals Inc to open at $33.08, and during the day (based on 14 day Average True Range), to move between $32.25 and $33.93, which gives a possible trading interval of +/-$1.69 (+/-5.23%) up or down from last closing price. If Crinetics Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 5.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $32.61 (1.45%) than the resistance at $34.71 (4.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Crinetics Pharmaceuticals Inc stock A Buy?
Crinetics Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-3.939
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $33.08 ( 0.0302%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CRNX Performance
Trading levels for CRNX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 34.11 | 3.08% |
| R2 | 33.72 | 1.89% |
| R1 | 33.47 | 1.16% |
| Price | 33.09 | |
| S1 | 32.69 | -1.22% |
| S2 | 32.44 | -1.95% |
| S3 | 32.05 | -3.14% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 38.44 | 16.17% |
| R2 | 37.48 | 13.27% |
| R1 | 34.71 | 4.90% |
| Price | 33.09 | |
| S1 | 32.61 | -1.45% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Crinetics Pharmaceuticals Inc Stock.
Buy CRNX